Journal article
Ab interno trabecular bypass surgery with iStent® and iStent inject® for open angle glaucoma.
- Neo YN Eye Treatment Centre, Whipps Cross Univeristy Hospital, Barts Health NHS Trust, London E11 1NR, UK.
- Panos GD Eye Treatment Centre, Whipps Cross Univeristy Hospital, Barts Health NHS Trust, London E11 1NR, UK.
- Gatzioufas Z Department of Ophthalmology, Basel University Hospital, Basel 4051, Switzerland.
- Vergados A Eye Treatment Centre, Whipps Cross Univeristy Hospital, Barts Health NHS Trust, London E11 1NR, UK.
- 2020-06-12
Published in:
- Therapeutic delivery. - 2020
English
Glaucoma is one of the leading causes of visual loss in industrialized world. Local lowering intra-ocular pressure drops are the first-line treatment for glaucoma. Penetrating and nonpenetrating surgery is considered when topical lowering intra-ocular pressure drops fail. Recently, the iStent® device has been introduced in the management of glaucoma nonresponding sufficiently to local treatment. In this review, we present the results of the trials concerning the efficacy and safety of iStent for the treatment of open angle glaucoma.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.4155/tde-2020-0045
- PMID 32522140
- Persistent URL
- https://sonar.ch/global/documents/174270
Statistics
Document views: 22
File downloads: